Clincosm LogoSign in Get a demo

homozygous familial hypercholesterolemia

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • NGGT006
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023

Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Aug 22, 2023

Homozygous Familial Hypercholesterolemia Trial in Worldwide (Evinacumab)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • Wilmington, Delaware
  • +10 more
Jan 30, 2023

Homozygous Familial Hypercholesterolemia Trial (Evinacumab)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Nov 3, 2022

Homozygous Familial Hypercholesterolemia Trial in Netherlands, South Africa, United States (Demographics, diagnosis type,

Recruiting
  • Homozygous Familial Hypercholesterolemia
  • Demographics, diagnosis type, genotype, lipid profile, treatment allocation, country of residence.
  • Philadelphia, Pennsylvania
  • +3 more
Sep 28, 2022

Homozygous Familial Hypercholesterolemia Trial in Australia, Canada, United States (ARO-ANG 3 Injection)

Recruiting
  • Homozygous Familial Hypercholesterolemia
  • ARO-ANG 3 Injection
  • Mount Sinai, New York
  • +7 more
Sep 26, 2022

Homozygous Familial Hypercholesterolemia Trial in Beijing (IBI306)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • IBI306
  • Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Sep 12, 2022

Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • Evanston, Illinois
  • +11 more
Jul 13, 2022

Homozygous Familial Hypercholesterolemia Trial in Worldwide (evinacumab)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • Los Angeles, California
  • +37 more
Feb 17, 2022

The Rogosin Institute Homozygous Familial Hypercholesterolemia

Recruiting
  • Homozygous Familial Hypercholesterolemia
    • New York, New York
      The Rogosin Institute, Weill Cornell Medical College
    Feb 28, 2022

    Ezetimibe onSelect Population of Filipinos With

    Completed
    Has Results
    • Primary Hypercholesterolemia
    • Homozygous Familial Hypercholesterolemia
    • (no location specified)
    Feb 7, 2022

    ASCVD, Elevated Cholesterol, Heterozygous Familial Hypercholesterolemia Trial in Worldwide (Inclisiran Sodium)

    Active, not recruiting
    • ASCVD
    • +3 more
    • Inclisiran Sodium
    • Birmingham, Alabama
    • +237 more
    Jan 26, 2022

    Homozygous Familial Hypercholesterolemia Trial in Worldwide (Alirocumab, Placebo)

    Completed
    Has Results
    • Homozygous Familial Hypercholesterolemia
    • Boca Raton, Florida
    • +27 more
    Jun 7, 2021

    Homozygous Familial Hypercholesterolemia Trial in France (Whole Genome Sequencing)

    Completed
    • Homozygous Familial Hypercholesterolemia
    • Whole Genome Sequencing
    • Dijon, France
    • +8 more
    May 21, 2021

    Homozygous Familial Hypercholesterolemia Trial in Worldwide (evinacumab, Placebo)

    Completed
    Has Results
    • Homozygous Familial Hypercholesterolemia
    • Boca Raton, Florida
    • +29 more
    Apr 26, 2021

    Homozygous Familial Hypercholesterolemia Trial in United States (Lomitapide)

    Recruiting
    • Homozygous Familial Hypercholesterolemia
    • Birmingham, Alabama
    • +46 more
    Dec 2, 2020

    Homozygous Familial Hypercholesterolemia Trial in Los Angeles, Amsterdam, Parktown (ALN-PCSSC, Standard of Care)

    Completed
    Has Results
    • Homozygous Familial Hypercholesterolemia
    • Los Angeles, California
    • +2 more
    May 14, 2020

    Homozygous Familial Hypercholesterolemia Trial in Canada, Netherlands, United States (REGN1500 250 mg SC/15 mg/kg IV/450 mg SC)

    Completed
    Has Results
    • Homozygous Familial Hypercholesterolemia
    • REGN1500 250 mg SC/15 mg/kg IV/450 mg SC
    • Los Angeles, California
    • +4 more
    Dec 6, 2019

    Homozygous Familial Hypercholesterolemia Trial in Beijing (AK102, Statins, Ezetimibe)

    Unknown status
    • Homozygous Familial Hypercholesterolemia
    • Beijing, Beijing, China
    • +1 more
    Nov 17, 2019

    Homozygous Familial Hypercholesterolemia, HoFH Trial in Los Angeles (HDL Therapeutics PDS-2 System)

    Unknown status
    • Homozygous Familial Hypercholesterolemia
    • HoFH
    • HDL Therapeutics PDS-2 System
    • Los Angeles, California
      Cedars-Sinai Medical Center (CSMC)
    May 21, 2019

    Homozygous Familial Hypercholesterolemia Trial in Québec (AKCEA-ANGPTL3-LRX)

    Withdrawn
    • Homozygous Familial Hypercholesterolemia
    • Québec, Quebec, Canada
      Clinical Site
    Nov 29, 2018

    Homozygous Familial Hypercholesterolemia Trial in Worldwide (Evolocumab, Placebo)

    Completed
    Has Results
    • Homozygous Familial Hypercholesterolemia
    • Evolocumab
    • Placebo
    • New York, New York
    • +20 more
    Nov 1, 2018

    Homozygous Familial Hypercholesterolemia Trial in Worldwide (AEGR-733)

    Completed
    Has Results
    • Homozygous Familial Hypercholesterolemia
    • Los Angeles, California
    • +9 more
    Feb 21, 2018

    Homozygous Familial Hypercholesterolemia Trial (Lomitapide)

    Withdrawn
    • Homozygous Familial Hypercholesterolemia
    • (no location specified)
    Feb 21, 2018

    Homozygous Familial Hypercholesterolemia Trial (Lomitapide)

    Withdrawn
    • Homozygous Familial Hypercholesterolemia
    • (no location specified)
    Dec 13, 2017